[HTML][HTML] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
DV Havlir, IC Marschner, MS Hirsch… - … England Journal of …, 1998 - Mass Medical Soc
Background Combination antiretroviral therapy with indinavir, zidovudine, and lamivudine
can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the …
can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the …
[HTML][HTML] A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously …
G Pialoux, F Raffi, F Brun-Vezinet… - … England Journal of …, 1998 - Mass Medical Soc
Background The long-term effectiveness of potent three-drug antiretroviral regimens for the
treatment of human immunodeficiency virus type 1 (HIV-1) infection is limited by problems …
treatment of human immunodeficiency virus type 1 (HIV-1) infection is limited by problems …
Predictors of Virologic and Clinical Outcomes in HIV-1–Infected Patients Receiving Concurrent Treatment with Indinavir, Zidovudine, and Lamivudine: AIDS Clinical …
LM Demeter, MD Hughes, RW Coombs… - Annals of internal …, 2001 - acpjournals.org
Background: A substantial proportion of patients with HIV infection will not respond to
antiretroviral therapy. Early predictors of response to treatment are needed to identify …
antiretroviral therapy. Early predictors of response to treatment are needed to identify …
[HTML][HTML] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
Background The new protease inhibitors are potent inhibitors of the human
immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be …
immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be …
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
D Descamps, P Flandre, V Calvez, G Peytavin… - Jama, 2000 - jamanetwork.com
ContextIn the Trilège trial, following induction with a zidovudine, lamivudine, and indinavir
regimen, human immunodeficiency virus (HIV) replication was less suppressed by 2-drug …
regimen, human immunodeficiency virus (HIV) replication was less suppressed by 2-drug …
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up
Context.—Combination antiretroviral therapy can markedly suppress human
immunodeficiency virus (HIV) replication but the duration of HIV suppression varies among …
immunodeficiency virus (HIV) replication but the duration of HIV suppression varies among …
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure
Potent antiretroviral therapy can reduce plasma HIV RNA levels below the threshold of
detection for periods of a year or more. The magnitude of HIV RNA reduction in the lymphoid …
detection for periods of a year or more. The magnitude of HIV RNA reduction in the lymphoid …
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine
Objective: To assess virological and immunological responses and toxicity in subjects
receiving combination antiretroviral therapy. Design: Six-year follow-up of a single arm of a …
receiving combination antiretroviral therapy. Design: Six-year follow-up of a single arm of a …
[HTML][HTML] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
SG Deeks, T Wrin, T Liegler, R Hoh… - … England Journal of …, 2001 - Mass Medical Soc
Background In many patients with human immunodeficiency virus (HIV) infection, therapy
with potent antiretroviral drugs does not result in complete suppression of HIV replication …
with potent antiretroviral drugs does not result in complete suppression of HIV replication …
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati, A Pan… - Antiviral …, 2002 - journals.sagepub.com
Current antiretroviral drugs cannot eradicate HIV infections, and persons living with HIV are
often faced with very demanding daily therapeutic schedules that can induce poor …
often faced with very demanding daily therapeutic schedules that can induce poor …